BackgroundCheck.run
Search For

Stuart L Dombey, 763030 Provincial Dr, Ann Arbor, MI 48104

Stuart Dombey Phones & Addresses

3030 Provincial Dr, Ann Arbor, MI 48104    734-3692433    734-3692436    734-3698120   

2800 Plymouth Rd, Ann Arbor, MI 48105    734-9961539   

7 Woodlane Rd, Lawrence Township, NJ 08648    609-8963085   

Trenton, NJ   

Fox, OK   

Basking Ridge, NJ   

3030 Provincial Dr, Ann Arbor, MI 48104    734-3584261   

Social networks

Stuart L Dombey

Linkedin

Work

Company: Parke-davis 1990 to 2000 Position: Vice president international regualtory affairs

Education

Degree: Bachelors, Bachelor of Medicine School / High School: Liverpool Medical School 1966 to 1971 Specialities: Medicine

Skills

Clinical Trials • Pharmaceutical Industry • Clinical Study Design • Osteoporosis

Emails

Industries

Pharmaceuticals

Mentions for Stuart L Dombey

Stuart Dombey resumes & CV records

Resumes

Stuart Dombey Photo 11

Chief Strategy Officer

Location:
Ann Arbor, MI
Industry:
Pharmaceuticals
Work:
Parke-Davis 1990 - 2000
Vice President International Regualtory Affairs
Pfizer 1990 - 2000
Vice President International Regulatory
Warner Lambert 1999 - 2000
Head of R and D Japan
Quatrx 1999 - 2000
Chief Strategy Officer
Pfizer 1990 - 1998
Vice President International Regualtory Affairs
Bristol-Myers Squibb 1987 - 1990
Vice President Regulatory Affairs
Bristol-Myers Squibb 1981 - 1987
Medical Drirector
Education:
Liverpool Medical School 1966 - 1971
Bachelors, Bachelor of Medicine, Medicine
Skills:
Clinical Trials, Pharmaceutical Industry, Clinical Study Design, Osteoporosis

Publications & IP owners

Us Patents

Methods For The Treatment Of Erectile Dysfunction Using Fispemifene

US Patent:
2010026, Oct 14, 2010
Filed:
Jun 8, 2010
Appl. No.:
12/795986
Inventors:
Robert L. Zerbe - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Assignee:
QUATRX PHARMACEUTICALS COMPANY - Ann Arbor MI
International Classification:
A61K 31/497
A61P 15/10
US Classification:
51425216
Abstract:
A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.

Methods For The Treatment Of Erectile Dysfunction Using Fispemifene

US Patent:
2013021, Aug 22, 2013
Filed:
Mar 21, 2013
Appl. No.:
13/848325
Inventors:
Robert L. Zerbe - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Assignee:
QuatRX Pharmaceuticals Company - Ann Arbor MI
International Classification:
A61K 31/085
A61K 31/519
A61K 31/4985
US Classification:
514250, 514720, 51425216
Abstract:
A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.

Methods For The Treatment Of Erectile Dysfunction Using Fispemifene

US Patent:
2008031, Dec 18, 2008
Filed:
Jun 13, 2008
Appl. No.:
12/138560
Inventors:
Robert L. Zerbe - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Assignee:
QUATRX PHARMACEUTICALS COMPANY - Ann Arbor MI
International Classification:
A61K 31/53
A61K 31/085
A61K 31/135
A61P 15/00
A61K 31/4985
A61K 31/496
US Classification:
514243, 514720, 514648, 51425216, 514250
Abstract:
A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.

Methods For The Treatment Of Erectile Dysfunction Using Fispemifene

US Patent:
2020006, Feb 27, 2020
Filed:
Nov 1, 2019
Appl. No.:
16/672112
Inventors:
- Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
International Classification:
A61K 31/085
A61K 31/4985
A61K 31/519
A61K 31/53
A61K 31/496
A61K 9/00
A61K 31/135
A61K 31/075
Abstract:
A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.